INNOVATIVE EYEWEAR, INC. Stock-Based Compensation
INNOVATIVE EYEWEAR, INC. (LUCY) reported Stock-Based Compensation of $399.32 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-14
- INNOVATIVE EYEWEAR, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $198.32K, a 20.41% increase year-over-year.
- INNOVATIVE EYEWEAR, INC. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $200.99K, a 13.19% increase year-over-year.
- INNOVATIVE EYEWEAR, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $206.15K, a 21.99% decline year-over-year.
- INNOVATIVE EYEWEAR, INC. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $189.73K, a 80.56% increase year-over-year.
- INNOVATIVE EYEWEAR, INC. share-based payment arrangement, noncash expense for fiscal 2025 was $738.17K, a 4.73% decline from fiscal 2024.
- INNOVATIVE EYEWEAR, INC. share-based payment arrangement, noncash expense for fiscal 2024 was $774.79K, a 17.29% decline from fiscal 2023.
- INNOVATIVE EYEWEAR, INC. share-based payment arrangement, noncash expense for fiscal 2023 was $936.77K, a 36.44% decline from fiscal 2022.
- INNOVATIVE EYEWEAR, INC. share-based payment arrangement, noncash expense for fiscal 2022 was $1.47M, a 10.41% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 3 month as first filed | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $198.32K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $399.32K 10-Q · filed 2026-08-14 | $605.47K derived: sum of 3 quarters · filed 2026-08-14 | $795.20K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $200.99K 10-Q · filed 2026-05-14 | $407.14K derived: sum of 2 quarters · filed 2026-05-14 | $596.87K derived: sum of 3 quarters · filed 2026-05-14 | $761.59K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | $206.15K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $395.88K derived: sum of 2 quarters · filed 2026-03-25 | $560.59K derived: sum of 3 quarters · filed 2026-08-14 | $738.17K 10-K · filed 2026-03-25 | ||
| 2025-09-30 | $189.73K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $354.44K derived: sum of 2 quarters · filed 2026-08-14 | $532.02K 10-Q · filed 2025-11-13 | $796.27K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $164.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $342.29K 10-Q · filed 2026-08-14 | $355.21K 10-Q · filed 2025-08-14 | $606.54K derived: sum of 3 quarters · filed 2026-08-14 | $711.62K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2025-03-31 | $177.58K 10-Q · filed 2026-05-14 | $183.00K 10-Q · filed 2025-05-13 | $441.83K derived: sum of 2 quarters · filed 2026-05-14 | $546.90K derived: sum of 3 quarters · filed 2026-05-14 | $720.21K derived: sum of 4 quarters · filed 2026-05-14 | |
| 2024-12-31 | $264.25K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-25 | $369.33K derived: sum of 2 quarters · filed 2026-03-25 | $542.63K derived: sum of 3 quarters · filed 2026-03-25 | $774.79K 10-K · filed 2026-03-25 | ||
| 2024-09-30 | $105.08K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $278.38K derived: sum of 2 quarters · filed 2025-11-13 | $510.53K 10-Q · filed 2025-11-13 | $820.82K derived: sum of 4 quarters · filed 2025-11-13 | ||
| 2024-06-30 | $173.31K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $405.46K 10-Q · filed 2025-08-14 | $715.74K derived: sum of 3 quarters · filed 2025-08-14 | $957.98K derived: sum of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | $232.15K 10-Q · filed 2025-05-13 | $542.44K derived: sum of 2 quarters · filed 2025-05-13 | $784.67K derived: sum of 3 quarters · filed 2025-05-13 | $744.49K derived: sum of 4 quarters · filed 2025-05-13 | ||
| 2023-12-31 | $310.28K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24 | $552.52K derived: sum of 2 quarters · filed 2025-03-24 | $512.34K derived: sum of 3 quarters · filed 2025-03-24 | $936.77K 10-K · filed 2025-03-24 | ||
| 2023-09-30 | $242.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $202.06K derived: sum of 2 quarters · filed 2024-11-12 | $626.49K 10-Q · filed 2024-11-12 | $961.21K derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | -$40.18K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | $384.25K 10-Q · filed 2024-08-12 | $718.97K derived: sum of 3 quarters · filed 2024-08-12 | $1.02M derived: sum of 4 quarters · filed 2024-08-12 | ||
| 2023-03-31 | $424.43K 10-Q · filed 2024-05-14 | $759.15K derived: sum of 2 quarters · filed 2024-05-14 | $1.06M derived: sum of 3 quarters · filed 2024-05-14 | $1.48M derived: sum of 4 quarters · filed 2024-05-14 | ||
| 2022-12-31 | $334.72K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $639.96K derived: sum of 2 quarters · filed 2024-03-25 | $1.06M derived: sum of 3 quarters · filed 2024-03-25 | $1.47M 10-K · filed 2024-03-25 | ||
| 2022-09-30 | $305.24K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $722.19K derived: sum of 2 quarters · filed 2023-11-14 | $1.14M 10-Q · filed 2023-11-14 | $1.78M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | $416.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $833.90K 10-Q · filed 2023-08-11 | $1.47M derived: sum of 3 quarters · filed 2023-08-11 | $1.97M derived: sum of 4 quarters · filed 2023-08-11 | ||
| 2022-03-31 | $416.95K 10-Q · filed 2023-05-12 | $1.06M derived: sum of 2 quarters · filed 2023-05-12 | $1.55M derived: sum of 3 quarters · filed 2023-05-12 | |||
| 2021-12-31 | $640.16K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-24 | $1.14M derived: sum of 2 quarters · filed 2023-03-24 | $1.33M 10-K · filed 2023-03-24 | |||
| 2021-09-30 | $495.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $694.77K 10-Q · filed 2022-11-10 | ||||
| 2021-06-30 | $199.00K 10-Q · filed 2022-09-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RxSight, Inc. (RXST) | United States | $0.197B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |